Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways Robert A. GatenbyKimberly A. LuddyJoel S. Brown Original Paper Open access 05 May 2024 Article: 135
A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways Md. Rezaul IslamAbdur RaufMuthu Thiruvengadam Review Article 04 May 2024 Article: 134
Research progress of immunotherapy for advanced head and neck cancer Anchi SunZhiwei XingHui Li Review Article 04 May 2024 Article: 133
Drug-loaded polymer-coated silver nanoparticles for lung cancer theranostics Ranjita MisraSubhenjit HazraSushmitha Nehru Original Paper 30 April 2024 Article: 132
NLRX1: a key regulator in mitochondrial respiration and colorectal cancer progression Yaxin DingWenjie SunRongrong Liu Original Paper 29 April 2024 Article: 131
In silico and network pharmacology analysis of fucosterol: a potent anticancer bioactive compound against HCC Kajal SinghPradeep KumarSunil Kumar Mishra Original Paper 27 April 2024 Article: 130
Retraction Note: Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway Shengyou GeKexin WangLin Wang Retraction Note 26 April 2024 Article: 129
Role of the STING pathway in myeloid neoplasms: a prospero-registered systematic review of principal hurdles of STING on the road to the clinical practice Leticia Rodrigues SampaioRicardo Dyllan Barbosa DiasRonald Feitosa Pinheiro Review Article 24 April 2024 Article: 128
A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases Salim Hussein HassanMohammad Y. AlshahraniAhmed Elawady Review Article 24 April 2024 Article: 127
Challenges and strategies in relation to effective CAR-T cell immunotherapy for solid tumors Guangxun YuanMengke YeXun Zeng Review Article 23 April 2024 Article: 126
Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives Alborz SoroushSiavash PourhosseinSepideh Karkon Shayan Review Article 23 April 2024 Article: 125
Ferroptosis is an effective strategy for cancer therapy Afrasyab KhanYu HuoYongzhong Hou Review Article 23 April 2024 Article: 124
Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy Abdur RaufPayal B. JoshiRekha Thiruvengadam Review Article 23 April 2024 Article: 122
N-methyl-D-aspartate receptors and thymoquinone induce apoptosis and alteration in mitochondria in colorectal cancer cells Ferhat SirinyildizSimge Unay Original Paper 23 April 2024 Article: 123
Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression Afrah Fatthi SalamaAli H. El-FarAlaa Elmetwalli Correction Open access 22 April 2024 Article: 121
FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner Zhe YinXiong GuoZiwei Wang Original Paper 20 April 2024 Article: 120
The role of SWI/SNF complexes in digestive system neoplasms Hanyun LiangXin ZhengJie Zheng Review Article 17 April 2024 Article: 119
Identification of small molecule inhibitors against Lin28/let-7 to suppress tumor progression and its alleviation role in LIN28-dependent glucose metabolism Rachanaa RajaRajamanikandan SundararajRuckmani Kandasamy Original Paper 17 April 2024 Article: 118
Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach Ahad Amer AlsaiariAmal F. GharibMohammed Ageeli Hakami Original Paper 17 April 2024 Article: 117
Liver cancer wars: plant-derived polyphenols strike back Chengu NiuJing ZhangPatrick I. Okolo 3rd Review Article 16 April 2024 Article: 116
Dual function of activated PPARγ by ligands on tumor growth and immunotherapy Mingjun ChenHuijie WangYongzhong Hou Review Article 15 April 2024 Article: 114
Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma Sohini RoyGeetha ShanmugamKoustav Sarkar Original Paper 15 April 2024 Article: 115
A novel α,β-unsaturated ketone inhibits leukemia cell growth as PARP1 inhibitor Weijia ZhaoMin MoBaofei Sun Original Paper 11 April 2024 Article: 113
Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies Khubaib AliMuhammad NabeelHamid Saeed Review Article 09 April 2024 Article: 112
Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights Ahmadreza LagzianMarziye AskariYalda Malekzadegan Review Aritcle 09 April 2024 Article: 108
Coadministration of doxorubicin with vitamin D3, Lactobacillus acidophilus, and Lactobacillus casei in the 4T1 mouse model of breast cancer: anticancer and enteroprotective effects Mohammad Ali MirzadehMajid EslamiAbbas Pakdel Original Paper 09 April 2024 Article: 111
Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer Shahnaz HosseinzadehMahsa ImaniElham Safarzadeh Original Paper 09 April 2024 Article: 110
Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line Nazli DemirkiranBengusu AydinH. Ogun Sercan Original Paper 09 April 2024 Article: 109
Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in non-small cell lung cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (TH) cell differentiation Nawaneetan SriramanAnkita SarkarKoustav Sarkar Original Paper 05 April 2024 Article: 107
Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment Alaa ElmetwalliMohamed O. Abdel-MonemMervat G. Hassan Original Paper Open access 04 April 2024 Article: 106
Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells Mohammed SalamaAbeer AliSeham Elabd Original Paper Open access 04 April 2024 Article: 105
Unlocking the potential: phenylboronic acid as a nuclear-targeting boron agent for neutron capture therapy Jiejian ChenYonghao LiGuolong Liu Original Paper 04 April 2024 Article: 104
Regulation of hippo signaling mediated apoptosis by Rauvolfia tetraphylla in triple-negative breast cancer B. BalavaishnaviM. KamarajMohammed Rafi Shaik Original Paper 29 March 2024 Article: 103
Investigating the correlation between prominent viruses and hematological malignancies: a literature review Arian HaghtalabMilad HejaziAtaollah GhalibafSabbaghi Review Article 28 March 2024 Article: 102
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer Abdulkarim S. BinshayaOmar Saad AlkahtaniHassan H. Almasoudi Original Paper 28 March 2024 Article: 101
Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review Sandipan DasguptaSakuntala GayenSouvik Roy Review Article 27 March 2024 Article: 98
YWHAG promotes colorectal cancer progression by regulating the CTTN-Wnt/β-catenin signaling axis Yuanben WangYulin CaoZhaohui Huang Original Paper 27 March 2024 Article: 100
Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer Anne-Dorthe Mosgaard KnudsenMikala Wej ModvigAnnette Raskov Kodahl Original Paper Open access 27 March 2024 Article: 99
Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach Bahar KartalFarika Nur Denizler-EbiriMehmet Taşpınar Original Paper Open access 26 March 2024 Article: 97
Regulation of cancer progression by CK2: an emerging therapeutic target Shakeel HussainYilei GuoYongzhong Hou Review Article 25 March 2024 Article: 94
Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment XiangFei ZhaoRuGang ZhaoYi Hu Original Paper 25 March 2024 Article: 96
Physical characterization and bioavailability assessment of 5-fluorouracil-based nanostructured lipid carrier (NLC): In vitro drug release, Hemolysis, and permeability modulation MainuddinAnoop KumarAmulya Jindal Original Paper 25 March 2024 Article: 95
Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing Kai XiongYuqi FangBo Zhu Original Paper 25 March 2024 Article: 93
Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines Hannah P. PriyankaUday P. PratapSrinivasan ThyagaRajan Original Paper 25 March 2024 Article: 92
The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinoma Qing-Qing LiuXiang-Xu WangHong-Mei Zhang Original Paper 25 March 2024 Article: 91
Design and evaluation of a multiepitope vaccine for pancreatic cancer using immune-dominant epitopes derived from the signature proteome in expression datasets Sooram BaneshNupoor PatilPrakash Saudagar Original Paper 24 March 2024 Article: 90
Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells Sneha KrishnamoorthyRajalakshmi SabanayagamSridhar Muthusami Original Paper 23 March 2024 Article: 89
In vitro anticancer activity of Hirudinaria manillensis methanolic extract and its validation using in silico molecular docking approach P. Zeebul Trinita ShannanSusan G. SuganyaM. Ramesh Original Paper 15 March 2024 Article: 88
Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancer Peipei WangYan PanXia Wang Review Article 12 March 2024 Article: 85
The cytotoxic effects of prazosin, chlorpromazine, and haloperidol on hepatocellular carcinoma and immortalized non-tumor liver cells Seth HarrisPrithvi NagarajanKyoungtae Kim Original Paper 12 March 2024 Article: 87
